pediatric patient

pediatric patient

Child, see there.
References in periodicals archive ?
Care of the Pediatric Patient With a Brain Tumor" includes information on epidemiology, classification of brain tumors, risk factors, genetics, pathophysiology, clinical features, tumor types, diagnostic testing, acute management, surgery, radiation therapy, chemotherapy, psychosocial and educational needs of the patient and family, and long-term effects of the brain tumor or management of the brain tumor.
In an observational cohort study of 10,566 pediatric patient encounters contained within the Michigan Emergency Records Management and Information Database (MERMaID), only 44% of the 1,118 drug administrations in pediatric patients were correct.
This allows the nursing team to focus on the clinical care of the pediatric patient.
To our knowledge, this is only tire second report of intraparenchymal parotid stones in a pediatric patient.
Shigella sonnei resistant to cefotaxime (but not to ceftazidime) was isolated for the first time in stool samples from a pediatric patient with vomiting and bloody diarrhea in northern Argentina.
This is a conservative estimate, but a realistic one that is based on concrete sales data for pediatric-focused products as well as pharmaceutical formulations prescribed commonly to the pediatric patient population.
Hospital-acquired infections are the leading cause of potentially preventable mortality among pediatric patients, according to a study of pediatric patient-safety incidents issued today by HealthGrades, the leading independent health care ratings organization.
Designed to minimize hemodilution and reduce foreign surface area exposure, the D101 is specially proportioned to the pediatric patient.
This course helps nurses provide optimal care for the highly specialized pediatric patient.
In order to determine the impact of this warning on antidepressant prescribing trends in the pediatric patient population, i3 Research examined de-identified health care claims data from a large U.
The result has been a push by developers and formulators emphasizing the creation of formulations engineered and packaged specifically for children to meet the needs of pediatric patient populations.
Fibrocell Science (FCSC) announced that it obtained allowance from the FDA to initiate enrollment of pediatric patients in the Phase 2 portion of the company's Phase 1/2 clinical trial of FCX-007, its gene therapy candidate being developed in collaboration with Intrexon Corporation (XON), for the treatment of recessive dystrophic epidermolysis bullosa-a devastating, genetic skin disease with high mortality.

Full browser ?